Advances in production and structural derivatization of the promising molecule ursolic acid

다국어 초록 (Multilingual Abstract)

Ursolic acid (UA) is a ursane‐type pentacyclic triterpenoid compound, naturally produced in plants via specialized metabolism and exhibits vast range of remarkable physiological activities and pharmacological manifestations. Owing to significant safety and efficacy in different medical conditions, UA may serve as a backbone to produce its derivatives with novel therapeutic functions. This review aims to provide ideas for exploring more diverse structures to improve UA pharmacological activity and increasing its biological yield to meet the industrial requirements by systematically reviewing the current research progress of UA. We first provides an overview of the pharmacological activities, acquisition methods and structural modifications of UA. Among them, we focused on the synthetic modifications of UA to yield valuable derivatives with enhanced therapeutic potential. Furthermore, harnessing the essential advances for green synthesis of UA and its derivatives by advent of metabolic engineering and synthetic biology are of great concern. In this regard, all pivotal advances for enhancing the production of UA have been discussed. In combination with the advantages of UA biosynthesis and transformation strategy, large‐scale microbial production of UA is a promising platform for further exploration.
Ursolic acid is naturally produced in plants via specialized metabolism and exhibits vast range of remarkable physiological activities and pharmacological manifestations, which serves as a backbone to produce its derivatives with novel therapeutic functions. In this review, we summarize the pharmacological activities, acquisition methods and structural modifications of UA. Among them, we focused on the transition towards the green synthesis of UA and its derivatives by employing biotechnological approaches.